A microbial supply chain for production of the anti-cancer drug vinblastine.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
09 2022
Historique:
received: 12 04 2021
accepted: 27 07 2022
pubmed: 1 9 2022
medline: 11 9 2022
entrez: 31 8 2022
Statut: ppublish

Résumé

Monoterpene indole alkaloids (MIAs) are a diverse family of complex plant secondary metabolites with many medicinal properties, including the essential anti-cancer therapeutics vinblastine and vincristine

Identifiants

pubmed: 36045295
doi: 10.1038/s41586-022-05157-3
pii: 10.1038/s41586-022-05157-3
pmc: PMC9452304
doi:

Substances chimiques

Antineoplastic Agents 0
Polyisoprenyl Phosphates 0
Vinca Alkaloids 0
Vinblastine 5V9KLZ54CY
geranyl pyrophosphate 763-10-0
Tryptophan 8DUH1N11BX
catharanthine WT0YJV846J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

341-347

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022. The Author(s).

Références

van Der Heijden, R., Jacobs, D. I., Snoeijer, W., Hallard, D. & Verpoorte, R. The Catharanthus alkaloids: pharmacognosy and biotechnology. Curr. Med. Chem. 11, 607–628 (2004).
doi: 10.2174/0929867043455846
Ishikawa, H. et al. Total synthesis of vinblastine, vincristine, related natural products, and key structural analogues. J. Am. Chem. Soc. 131, 4904–4916 (2009).
doi: 10.1021/ja809842b pubmed: 19292450 pmcid: 2727944
Jeong, W. T. & Lim, H. B. A UPLC-ESI-Q-TOF method for rapid and reliable identification and quantification of major indole alkaloids in Catharanthus roseus. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 1080, 27–36 (2018).
doi: 10.1016/j.jchromb.2018.02.018 pubmed: 29477064
Brown, S., Clastre, M., Courdavault, V. & O’Connor, S. E. De novo production of the plant-derived alkaloid strictosidine in yeast. Proc. Natl Acad. Sci. USA 112, 3205–3210 (2015).
doi: 10.1073/pnas.1423555112 pubmed: 25675512 pmcid: 4371906
O’Connor, S. E. & Maresh, J. J. Chemistry and biology of monoterpene indole alkaloid biosynthesis. Nat. Prod. Rep. 23, 532–547 (2006).
doi: 10.1039/b512615k pubmed: 16874388
Prasad, V. & Mailankody, S. Research and development spending to bring a single cancer drug to market and revenues after approvall. JAMA Intern. Med. 177, 1569–1575 (2017).
doi: 10.1001/jamainternmed.2017.3601 pubmed: 28892524 pmcid: 5710275
Krengel, F., Mijangos, M. V., Reyes-Lezama, M. & Reyes-Chilpa, R. Extraction and conversion studies of the antiaddictive alkaloids coronaridine, ibogamine, voacangine, and ibogaine from two Mexican Tabernaemontana species (Apocynaceae). Chem. Biodivers. 16, e1900175 (2019).
pubmed: 31095891
Ferreres, F. et al. Simple and reproducible HPLC-DAD-ESI-MS/MS analysis of alkaloids in Catharanthus roseus roots. J. Pharm. Biomed. Anal. 51, 65–69 (2010).
doi: 10.1016/j.jpba.2009.08.005 pubmed: 19720492
Verma, A., Laakso, I., Seppänen-Laakso, T., Huhtikangas, A. & Riekkola, M.-L. A simplified procedure for indole alkaloid extraction from Catharanthus roseus combined with a semi-synthetic production process for vinblastine. Molecules 12, 1307–1315 (2007).
doi: 10.3390/12071307 pubmed: 17909486 pmcid: 6149338
Boon, B. A. & Boger, D. L. Triarylaminium radical cation promoted coupling of catharanthine with vindoline: diastereospecific synthesis of anhydrovinblastine and reaction scope. J. Am. Chem. Soc. 141, 14349–14355 (2019).
doi: 10.1021/jacs.9b06968 pubmed: 31442047 pmcid: 6750708
Fox, E. R. & Unguru, Y. Oncology drug shortages in the USA–business as usual. Nat. Rev. Clin. Oncol. 17, 128–129 (2020).
doi: 10.1038/s41571-019-0318-x pubmed: 31831853
Li, Y. et al. Complete biosynthesis of noscapine and halogenated alkaloids in yeast. Proc. Natl Acad. Sci. USA 115, E3922–E3931 (2018).
pubmed: 29610307 pmcid: 5924921
Ro, D. K. et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440, 940–943 (2006).
doi: 10.1038/nature04640 pubmed: 16612385
Thodey, K., Galanie, S. & Smolke, C. D. A microbial biomanufacturing platform for natural and semisynthetic opioids. Nat. Chem. Biol. 10, 837–844 (2014).
doi: 10.1038/nchembio.1613 pubmed: 25151135 pmcid: 4167936
Luo, X. et al. Complete biosynthesis of cannabinoids and their unnatural analogues in yeast. Nature 567, 123–126 (2019).
doi: 10.1038/s41586-019-0978-9 pubmed: 30814733
Srinivasan, P. & Smolke, C. D. Biosynthesis of medicinal tropane alkaloids in yeast. Nature 585, 614–619 (2020).
doi: 10.1038/s41586-020-2650-9 pubmed: 32879484 pmcid: 7529995
Qu, Y. et al. Completion of the seven-step pathway from tabersonine to the anticancer drug precursor vindoline and its assembly in yeast. Proc. Natl Acad. Sci. USA 112, 6224–6229 (2015).
doi: 10.1073/pnas.1501821112 pubmed: 25918424 pmcid: 4434687
Liu, T. et al. Construction of ajmalicine and sanguinarine de novo biosynthetic pathways using stable integration sites in yeast. Biotechnol. Bioeng. 119, 1314–1326 (2022).
doi: 10.1002/bit.28040 pubmed: 35060115
Kulagina, N. et al. Enhanced bioproduction of anticancer precursor vindoline by yeast cell factories. Microb. Biotechnol. 14, 2693–2699 (2021).
doi: 10.1111/1751-7915.13898 pubmed: 34302444 pmcid: 8601169
Caputi, L. et al. Missing enzymes in the biosynthesis of the anticancer drug vinblastine in Madagascar periwinkle. Science 360, 1235–1239 (2018).
doi: 10.1126/science.aat4100 pubmed: 29724909
Qu, Y., Safonova, O. & De Luca, V. Completion of the canonical pathway for assembly of anticancer drugs vincristine/vinblastine in Catharanthus roseus. Plant J. 97, 257–266 (2019).
doi: 10.1111/tpj.14111 pubmed: 30256480
Simkin, A. J. et al. Characterization of the plastidial geraniol synthase from Madagascar periwinkle which initiates the monoterpenoid branch of the alkaloid pathway in internal phloem associated parenchyma. Phytochemistry 85, 36–43 (2013).
doi: 10.1016/j.phytochem.2012.09.014 pubmed: 23102596
Guirimand, G. et al. Strictosidine activation in Apocynaceae: towards a ‘nuclear time bomb’? BMC Plant Biol. 10, 182 (2010).
doi: 10.1186/1471-2229-10-182 pubmed: 20723215 pmcid: 3095312
Courdavault, V. et al. A look inside an alkaloid multisite plant: the Catharanthus logistics. Curr. Opin. Plant Biol. 19, 43–50 (2014).
doi: 10.1016/j.pbi.2014.03.010 pubmed: 24727073
Costa, M. M. R. et al. Molecular cloning and characterization of a vacuolar class III peroxidase involved in the metabolism of anticancer alkaloids in Catharanthus roseus. Plant Physiol. 146, 403–417 (2008).
doi: 10.1104/pp.107.107060 pubmed: 18065566 pmcid: 2245823
Billingsley, J. M. et al. Engineering the biocatalytic selectivity of iridoid production in Saccharomyces cerevisiae. Metab. Eng. 44, 117–125 (2017).
doi: 10.1016/j.ymben.2017.09.006 pubmed: 28939278 pmcid: 5705256
Galanie, S., Thodey, K., Trenchard, I. J., Filsinger Interrante, M. & Smolke, C. D. Complete biosynthesis of opioids in yeast. Science 349, 1095–1100 (2015).
doi: 10.1126/science.aac9373 pubmed: 26272907 pmcid: 4924617
Lichman, B. R. et al. Uncoupled activation and cyclization in catmint reductive terpenoid biosynthesis. Nat. Chem. Biol. 15, 71–79 (2019).
doi: 10.1038/s41589-018-0185-2 pubmed: 30531909
Lichman, B. R. et al. The evolutionary origins of the cat attractant nepetalactone in catnip. Sci. Adv. 6, eaba0721 (2020).
doi: 10.1126/sciadv.aba0721 pubmed: 32426505 pmcid: 7220310
Scalcinati, G. et al. Dynamic control of gene expression in Saccharomyces cerevisiae engineered for the production of plant sesquitepene α-santalene in a fed-batch mode. Metab. Eng. 14, 91–103 (2012).
doi: 10.1016/j.ymben.2012.01.007 pubmed: 22330799
Burke, C. & Croteau, R. Geranyl diphosphate synthase from Abies grandis: cDNA isolation, functional expression, and characterization. Arch. Biochem. Biophys. 405, 130–136 (2002).
doi: 10.1016/S0003-9861(02)00335-1 pubmed: 12176066
Stanley Fernandez, S. M., Kellogg, B. A. & Poulter, C. D. Farnesyl diphosphate synthase. Altering the catalytic site to select for geranyl diphosphate activity. Biochemistry 39, 15316–15321 (2000).
doi: 10.1021/bi0014305 pubmed: 11112517
Ignea, C., Pontini, M., Maffei, M. E., Makris, A. M. & Kampranis, S. C. Engineering monoterpene production in yeast using a synthetic dominant negative geranyl diphosphate synthase. ACS Synth. Biol. 3, 298–306 (2014).
doi: 10.1021/sb400115e pubmed: 24847684
Polakowski, T., Stahl, U. & Lang, C. Overexpression of a cytosolic hydroxymethylglutaryl-CoA reductase leads to squalene accumulation in yeast. Appl. Microbiol. Biotechnol. 49, 66–71 (1998).
doi: 10.1007/s002530051138 pubmed: 9487712
Stavrinides, A. et al. Unlocking the diversity of alkaloids in Catharanthus roseus: nuclear localization suggests metabolic channeling in secondary metabolism. Chem. Biol. 22, 336–341 (2015).
doi: 10.1016/j.chembiol.2015.02.006 pubmed: 25772467 pmcid: 4372254
Geerlings, A., Ibañez, M. M. & Memelink, J. Molecular cloning and analysis of strictosidine β-D-glucosidase, an enzyme in terpenoid indole alkaloid biosynthesis in Catharanthus roseus. J. Biol. Chem. 275, 3051–3056 (2000).
doi: 10.1074/jbc.275.5.3051 pubmed: 10652285
Peter Kutney, J. et al. A highly efficient and commercially important synthesis of the antitumor Catharanthus alkaloids vinblastine and leurosidine from catharanthine and vindoline. Heterocycles 27, 1845 (1988).
doi: 10.3987/COM-88-4611
Hirata, K. et al. Biomimetic one-pot synthesis of vinblastine: NAD(P)H-mediated vinblastine synthesis from the product of FMN-mediated vindoline–catharanthine coupling under near-ultraviolet light. Biotechnol. Lett 19, 53–57 (1997).
doi: 10.1023/A:1018367020754
US Food & Drug Administration. FDA Drug Shortages: Root Causes and Potential Solutions (FDA, 2019); https://www.fda.gov/media/132058/download
Gotoh, H., Duncan, K. K., Robertson, W. M. & Boger, D. L. 10’-Fluorovinblastine and 10’-fluorovincristine: synthesis of a key series of modified vinca alkaloids. ACS Med. Chem. Lett. 2, 948–952 (2011).
doi: 10.1021/ml200236a pubmed: 22247789 pmcid: 3254105
Stander, E. A. et al. Identifying genes involved in alkaloid biosynthesis in vinca minor through transcriptomics and gene co-expression analysis. Biomolecules 10, 1595 (2020).
doi: 10.3390/biom10121595 pmcid: 7761029
Camacho, C. et al. BLAST+: architecture and applications. BMC Bioinf. 10, 421 (2009).
doi: 10.1186/1471-2105-10-421
Nour-Eldin, H. H., Hansen, B. G., Nørholm, M. H. H., Jensen, J. K. & Halkier, B. A. Advancing uracil-excision based cloning towards an ideal technique for cloning PCR fragments. Nucleic Acids Res. 34, e122 (2006).
doi: 10.1093/nar/gkl635 pubmed: 17000637 pmcid: 1635280
Gietz, R. D. & Schiestl, R. H. Quick and easy yeast transformation using the LiAc/SS carrier DNA/PEG method. Nat. Protoc. 2, 35–37 (2007).
doi: 10.1038/nprot.2007.14 pubmed: 17401335
Jakočiūnas, T. et al. CasEMBLR: Cas9-facilitated multiloci genomic integration of in vivo assembled DNA parts in Saccharomyces cerevisiae. ACS Synth. Biol. 4, 1226–34 (2015).
doi: 10.1021/acssynbio.5b00007 pubmed: 25781611
Jensen, N. B. et al. EasyClone: method for iterative chromosomal integration of multiple genes in Saccharomyces cerevisiae. FEMS Yeast Res. 14, 238–248 (2014).
doi: 10.1111/1567-1364.12118 pubmed: 24151867
Zhu, J. et al. A validated set of fluorescent-protein-based markers for major organelles in yeast (Saccharomyces cerevisiae). mBio 10, e01691–19 (2019).
pubmed: 31481383 pmcid: 6722415
Gin, J., Chen, Y. & Petzold, C. Chloroform-methanol protein extraction with zymolyase treatment for yeast (high throughput) v1 (protocols.Io.Bhptj5nn). protocols.io https://doi.org/10.17504/protocols.io.bhptj5nn (2020).
Chen, Y., Gin, J. & Petzold, C. Targeted proteomic LC-MS/MS analysis v1 (protocols.io.bf9xjr7n). protocols.io https://doi.org/10.17504/protocols.io.bf9xjr7n (2020).
Wright, N. R. et al. Fluctuations in glucose availability prevent global proteome changes and physiological transition during prolonged chemostat cultivations of Saccharomyces cerevisiae. Biotechnol. Bioeng. 117, 2074–2088 (2020).
doi: 10.1002/bit.27353 pubmed: 32277712

Auteurs

Jie Zhang (J)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.

Lea G Hansen (LG)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.

Olga Gudich (O)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.

Konrad Viehrig (K)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.

Lærke M M Lassen (LMM)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.

Lars Schrübbers (L)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.

Khem B Adhikari (KB)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.

Paulina Rubaszka (P)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.

Elena Carrasquer-Alvarez (E)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.

Ling Chen (L)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.

Vasil D'Ambrosio (V)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.

Beata Lehka (B)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.

Ahmad K Haidar (AK)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.

Saranya Nallapareddy (S)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.

Konstantina Giannakou (K)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.

Marcos Laloux (M)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.

Dushica Arsovska (D)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.

Marcus A K Jørgensen (MAK)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.

Leanne Jade G Chan (LJG)

Joint BioEnergy Institute, Emeryville, CA, USA.
Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.

Mette Kristensen (M)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.

Hanne B Christensen (HB)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.

Suresh Sudarsan (S)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.

Emily A Stander (EA)

EA2106 Biomolecules and Plant Biotechnology, University of Tours, Tours, France.

Edward Baidoo (E)

Joint BioEnergy Institute, Emeryville, CA, USA.
Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.

Christopher J Petzold (CJ)

Joint BioEnergy Institute, Emeryville, CA, USA.
Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.

Tune Wulff (T)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.

Sarah E O'Connor (SE)

Department of Natural Product Biosynthesis, Max Planck Institute for Chemical Ecology, Jena, Germany.

Vincent Courdavault (V)

EA2106 Biomolecules and Plant Biotechnology, University of Tours, Tours, France.

Michael K Jensen (MK)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark. mije@biosustain.dtu.dk.

Jay D Keasling (JD)

Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark. keasling@berkeley.edu.
Joint BioEnergy Institute, Emeryville, CA, USA. keasling@berkeley.edu.
Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA. keasling@berkeley.edu.
Department of Chemical and Biomolecular Engineering, Department of Bioengineering, University of California, Berkeley, CA, USA. keasling@berkeley.edu.
Center for Synthetic Biochemistry, Institute for Synthetic Biology, Shenzhen Institutes of Advanced Technologies, Shenzhen, China. keasling@berkeley.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs
Humans Male Female Health Knowledge, Attitudes, Practice Middle Aged
Capsicum Disease Resistance Plant Diseases Polymorphism, Single Nucleotide Ralstonia solanacearum
Humans Female Alopecia Breast Neoplasms Middle Aged

Classifications MeSH